Loading...
Loading...
All product recalls affecting Louisiana.
Includes nationwide recalls (tagged “Nationwide”) and recalls with Louisiana in the distribution area.
Product label includes the ingredient CREAM but does not include Milk as the source.
Product label includes the ingredient CREAM but does not include Milk as the source.
Ford Motor Company (Ford) is recalling certain 2025 Lincoln Navigator, F-150, Expedition, Bronco, and Ranger vehicles. The Electronic Brake Booster (EBB) module may malfunction while driving or when the driver is utilizing an Advanced Driver Assistance System (ADAS) feature, resulting in a loss of power brake assist.
Listeria monocytogenes. During routine testing the firm received positive test results for Listeria monocytogenes.
Product label includes the ingredient CREAM but does not include Milk as the source.
Product label includes the ingredient CREAM but does not include Milk as the source.
Product label includes the ingredient CREAM but does not include Milk as the source.
Product label includes the ingredient CREAM but does not include Milk as the source.
Product label includes the ingredient CREAM but does not include Milk as the source.
Product label includes the ingredient CREAM but does not include Milk as the source.
Product label includes the ingredient CREAM but does not include Milk as the source.
CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
Product label includes the ingredient CREAM but does not include Milk as the source.
Product label includes the ingredient CREAM but does not include Milk as the source.
General Motors (GM) is recalling certain 2026 Cadillac VISTIQ vehicles and 2025 Cadillac LYRIQ vehicles. The bolts attaching the high voltage battery to the interior floor may be missing or loose.
Affected lead models may experience gradually rising LVSI measurements in association with calcification of the defibrillation lead coils. The issue may lead to early lead replacement. Most serious harm is death or need for cardiac resuscitation.
The defect in the thread area will not allow the device to fully engage with an implant or analog (implant replica used for prosthetic modeling). The threads will only engage approximately 2 rotations as opposed to full engagement which is approximately 5 rotations. This equates to approximately 1mm difference in depth of engagement.
The defect in the thread area will not allow the device to fully engage with an implant or analog (implant replica used for prosthetic modeling). The threads will only engage approximately 2 rotations as opposed to full engagement which is approximately 5 rotations. This equates to approximately 1mm difference in depth of engagement.
The affected devices are the Dexcom G7 Continuous Glucose Monitoring System (CGM System) using iOS, watchOS and Android App software (versions 2.8.0 or earlier) and Dexcom ONE+ CGM System using iOS and Android App software (versions 1.4.0 or earlier), henceforth referred to as the App. The affected App does not provide an expected "Sensor Failed" alert when the transmitter sends a "transmitterFailed" error message to the App when the CGM experiences a hardware or firmware failure. Instead, the App ends the CGM sensor session, stops reporting glucose values and displays the Start Sensor screen or No active sensor message without alerting the user, which can lead to missed detection of a hyperglycemic or hypoglycemic event and a delay in treatment.
The affected devices are the Dexcom G7 Continuous Glucose Monitoring System (CGM System) using iOS, watchOS and Android App software (versions 2.8.0 or earlier) and Dexcom ONE+ CGM System using iOS and Android App software (versions 1.4.0 or earlier), henceforth referred to as the App. The affected App does not provide an expected "Sensor Failed" alert when the transmitter sends a "transmitterFailed" error message to the App when the CGM experiences a hardware or firmware failure. Instead, the App ends the CGM sensor session, stops reporting glucose values and displays the Start Sensor screen or No active sensor message without alerting the user, which can lead to missed detection of a hyperglycemic or hypoglycemic event and a delay in treatment.